I'm LongbridgeAI, I can summarize articles.CSPC PHARMA (01093.HK) +0.315 (+3.945%) Short selling $335.37M; Ratio 31.537% announced that its subsidiary CStone Pharmaceuticals received a USD15 million development milestone payment from Corbus Pharmaceuticals related to CRB-701 (SYS 6002).
To date, CStone Pharmaceuticals has cumulatively received upfront and development milestone payments totaling USD32.5 million from Corbus Pharmaceuticals under the agreement.
The achievement of this milestone marks the steady progress of the relevant R&D work under the agreement as planned. (sl/u)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-11-19 16:25.)
